$1.98
-0.06 (-2.94%)
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+975.8% upside
Low Target
$14.71
Average Target
$21.30
High Target
$34.17
Current Price
$1.98
Current
$1.98
$1.98
Target
$21.30
$21.30
$14.71
$21.30 avg
$34.17
Scenario Analysis
Bear Case
$14.71
642.9%
Low target
Base Case
$21.30
+975.8%
Avg target
Bull Case
$34.17
+1,625.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$3.40
-41.8% from high
52-Week Low
$1.09
+81.7% from low
Target vs 52W High
$21.30
+526.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |